News Focus
News Focus
Followers 8
Posts 494
Boards Moderated 0
Alias Born 03/06/2022

Re: tradeherpete post# 516716

Thursday, 04/02/2026 1:06:42 PM

Thursday, April 02, 2026 1:06:42 PM

Post# of 518999
You might go ahead and ask whichever A1 you selected to tell us how much efficacy LEQEMBI (Lecanemab) demonstrated in reducing cognitive decline for women, who represent about two-thirds of all Alzheimer's patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News